 Home > Biochemistry News > Biotechnology News > Over 400 million US dollars!

Over 400 million US dollars!

 Last Update: 2021-08-07
 Source: Internet
 Author: User

Tags

biotechnology

scope

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Source: Guanlan Pharmaceutical

On June 28, Chuangxiang Bio and Ancheng Biotechnology announced that they had reached an agreement on the joint development of AC-1101, a new drug developed by Ancheng Biotechnology

According to the terms of the agreement, Ancheng Biotechnology will grant Chuangxiang Bio-AC-1101 the exclusive joint development rights to conduct global phase 1b clinical studies in a selected dermatological indication

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Express targeting RNA-modified protein to treat leukemia, Ipsen reached over 400 million US dollars in cooperation

11-05

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Over 400 million US dollars!

Related Articles

Express targeting RNA-modified protein to treat leukemia, Ipsen reached over 400 million US dollars in cooperation